Strategies for Controlling Biofilm-forming Microbial Pathogens on Biotic
and Abiotic Surfaces

Fazlurrahman      Khan
doi:10.2174/1389450123666220429115255
« Previous Next »
[1] 
Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol  2002; 292(2): 107-13.
[http://dx.doi.org/10.1078/1438-4221-00196] [PMID: 12195733] 
[2] 
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents  2010; 35(4): 322-32.
[http://dx.doi.org/10.1016/j.ijantimicag.2009.12.011] [PMID: 20149602] 
[3] 
Kernien JF, Snarr BD, Sheppard DC, Nett JE. The interface between fungal biofilms and innate immunity. Front Immunol  2018; 8: 1968.
[http://dx.doi.org/10.3389/fimmu.2017.01968] [PMID: 29375581] 
[4] 
Schulze A, Mitterer F, Pombo JP, Schild S. Biofilms by bacterial human pathogens: Clinical relevance - development, composition and regulation - therapeutical strategies. Microb Cell  2021; 8(2): 28-56.
[http://dx.doi.org/10.15698/mic2021.02.741] [PMID: 33553418] 
[5] 
Arzmi MH, Alnuaimi AD, Dashper S, Cirillo N, Reynolds EC, McCullough M. Polymicrobial biofilm formation by Candida albicans, Actinomyces naeslundii, and Streptococcus mutans is Candida albicans strain and medium dependent. Med Mycol  2016; 54(8): 856-64.
[http://dx.doi.org/10.1093/mmy/myw042] [PMID: 27354487] 
[6] 
Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet  2022; 399(10325): 629-55.
[http://dx.doi.org/10.1016/S0140-6736(21)02724-0] [PMID: 35065702] 
[7] 
Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol  2010; 8(9): 623-33.
[http://dx.doi.org/10.1038/nrmicro2415] [PMID: 20676145] 
[8] 
Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis  2002; 8(9): 881-90.
[http://dx.doi.org/10.3201/eid0809.020063] [PMID: 12194761] 
[9] 
Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science  2002; 295(5559): 1487-7.
[http://dx.doi.org/10.1126/science.295.5559.1487] [PMID: 11859186] 
[10] 
Costa OYA, Raaijmakers JM, Kuramae EE. Microbial extracellular polymeric substances: Ecological function and impact on soil aggrega-tion. Front Microbiol  2018; 9: 1636.
[http://dx.doi.org/10.3389/fmicb.2018.01636] [PMID: 30083145] 
[11] 
Lopez-Ribot JL. Large-scale biochemical profiling of the Candida albicans biofilm matrix: New compositional, structural, and functional insights. MBio  2014; 5(5): e01781-14.
[http://dx.doi.org/10.1128/mBio.01781-14] [PMID: 25205098] 
[12] 
Wolfaardt GM, Lawrence JR, Korber DR. Function of EPSMicrobial extracellular polymeric substances.  Springer 1999; pp. 171-200.
[http://dx.doi.org/10.1007/978-3-642-60147-7_10] 
[13] 
Zhang K, Li X, Yu C, Wang Y. Promising therapeutic strategies against microbial biofilm challenges. Front Cell Infect Microbiol  2020; 10: 359.
[http://dx.doi.org/10.3389/fcimb.2020.00359] [PMID: 32850471] 
[14] 
Khan F, Pham DTN, Tabassum N, Oloketuyi SF, Kim YM. Treatment strategies targeting persister cell formation in bacterial pathogens. Crit Rev Microbiol  2020; 46(6): 665-88.
[http://dx.doi.org/10.1080/1040841X.2020.1822278] [PMID: 33022189] 
[15] 
Wuyts J, Van Dijck P, Holtappels M. Fungal persister cells: The basis for recalcitrant infections? PLoS Pathog  2018; 14(10): e1007301.
[http://dx.doi.org/10.1371/journal.ppat.1007301] [PMID: 30335865] 
[16] 
Fisher RA, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat Rev Microbiol  2017; 15(8): 453-64.
[http://dx.doi.org/10.1038/nrmicro.2017.42] [PMID: 28529326] 
[17] 
Khatoon Z, McTiernan CD, Suuronen EJ, Mah TF, Alarcon EI. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon  2018; 4(12): e01067.
[http://dx.doi.org/10.1016/j.heliyon.2018.e01067] [PMID: 30619958] 
[18] 
Galié S, García-Gutiérrez C, Miguélez EM, Villar CJ, Lombó F. Biofilms in the food industry: Health aspects and control methods. Front Microbiol  2018; 9: 898.
[http://dx.doi.org/10.3389/fmicb.2018.00898] [PMID: 29867809] 
[19] 
Abdallah M, Benoliel C, Drider D, Dhulster P, Chihib NE. Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments. Arch Microbiol  2014; 196(7): 453-72.
[http://dx.doi.org/10.1007/s00203-014-0983-1] [PMID: 24744186] 
[20] 
Carter MQ, Brandl MT. Biofilms in fresh vegetables and fruits. In: Biofilms in the Food Environment.   2015; pp. 176-204.
[http://dx.doi.org/10.1002/9781118864036.ch7] 
[21] 
Ng CG, Loke MF, Goh KL, Vadivelu J, Ho B. Biofilm formation enhances Helicobacter pylori survivability in vegetables. Food Microbiol  2017; 62: 68-76.
[http://dx.doi.org/10.1016/j.fm.2016.10.010] [PMID: 27889168] 
[22] 
Jahid IK, Ha S-D. A review of microbial biofilms of produce: Future challenge to food safety. Food Sci Biotechnol  2012; 21(2): 299-316.
[http://dx.doi.org/10.1007/s10068-012-0041-1] 
[23] 
Han N, Mizan MFR, Jahid IK, Ha S-D. Biofilm formation by Vibrio parahaemolyticus on food and food contact surfaces increases with rise in temperature. Food Control  2016; 70: 161-6.
[http://dx.doi.org/10.1016/j.foodcont.2016.05.054] 
[24] 
Cappitelli F, Polo A, Villa F. Biofilm formation in food processing environments is still poorly understood and controlled. Food Eng Rev  2014; 6(1): 29-42.
[http://dx.doi.org/10.1007/s12393-014-9077-8] 
[25] 
Cantón R, Morosini M-I. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev  2011; 35(5): 977-91.
[http://dx.doi.org/10.1111/j.1574-6976.2011.00295.x] [PMID: 21722146] 
[26] 
Khan F, Park SK, Bamunuarachchi NI, Oh D, Kim YM. Caffeine-loaded gold nanoparticles: Antibiofilm and anti-persister activities against pathogenic bacteria. Appl Microbiol Biotechnol  2021; 105(9): 3717-31.
[http://dx.doi.org/10.1007/s00253-021-11300-3] [PMID: 33900427] 
[27] 
Bamunuarachchi NI, Khan F, Kim YM. Inhibition of virulence factors and biofilm formation of Acinetobacter baumannii by naturally-derived and synthetic drugs. Curr Drug Targets  2021; 22(7): 734-59.
[http://dx.doi.org/10.2174/1389450121666201023122355] [PMID: 33100201] 
[28] 
Khan F, Pham DTN, Kim YM. Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria. Appl Microbiol Biotechnol  2020; 104(5): 1955-76.
[http://dx.doi.org/10.1007/s00253-020-10360-1] [PMID: 31970432] 
[29] 
Khan F, Khan MM, Kim YM. Recent progress and future perspectives of antibiofilm drugs immobilized on nanomaterials. Curr Pharm Biotechnol  2018; 19(8): 631-43.
[http://dx.doi.org/10.2174/1389201019666180828090052] [PMID: 30152281] 
[30] 
Barros CHN, Casey E. A review of nanomaterials and technologies for enhancing the antibiofilm activity of natural products and phyto-chemicals. ACS Appl Nano Mater  2020; 3(9): 8537-56.
[http://dx.doi.org/10.1021/acsanm.0c01586] 
[31] 
Tran HM, Tran H, Booth MA, et al. Nanomaterials for treating bacterial biofilms on implantable medical devices. Nanomaterials (Basel)  2020; 10(11): E2253.
[http://dx.doi.org/10.3390/nano10112253] [PMID: 33203046] 
[32] 
Li X, Sun L, Zhang P, Wang Y. Novel approaches to combat medical device-associated biofilms. Coatings  2021; 11(3): 294.
[http://dx.doi.org/10.3390/coatings11030294] 
[33] 
P S V V S N.. A Review on surface modifications and coatings on implants to prevent biofilm. Regen Eng Transl Med  2020; 6(3): 330-46.
[http://dx.doi.org/10.1007/s40883-019-00116-3] 
[34] 
Di Somma A, Moretta A, Canè C, Cirillo A, Duilio A. Antimicrobial and antibiofilm peptides. Biomolecules  2020; 10(4): 652.
[http://dx.doi.org/10.3390/biom10040652] [PMID: 32340301] 
[35] 
Fleming D, Rumbaugh KP. Approaches to dispersing medical biofilms. Microorganisms  2017; 5(2): 15.
[http://dx.doi.org/10.3390/microorganisms5020015] [PMID: 28368320] 
[36] 
Wood S, Nattress B, Kirkham J, et al. An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J Photochem Photobiol B  1999; 50(1): 1-7.
[http://dx.doi.org/10.1016/S1011-1344(99)00056-1] [PMID: 10443029] 
[37] 
Tahmassebi JF, Drogkari E, Wood SR. A study of the control of oral plaque biofilms via antibacterial photodynamic therapy. Eur Arch Paediatr Dent  2015; 16(6): 433-40.
[http://dx.doi.org/10.1007/s40368-014-0165-5] [PMID: 26385341] 
[38] 
Tian F, Li J, Nazir A, Tong Y. Bacteriophage - A promising alternative measure for bacterial biofilm control. Infect Drug Resist  2021; 14: 205-17.
[http://dx.doi.org/10.2147/IDR.S290093] [PMID: 33505163] 
[39] 
Mai-Prochnow A, Zhou R, Zhang T, et al. Interactions of plasma-activated water with biofilms: Inactivation, dispersal effects and mechanisms of action. npj Biofilms Microbiomes  2021; 7(1): 1.
[40] 
Parrino B, Schillaci D, Carnevale I, et al. Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance. Eur J Med Chem  2019; 161: 154-78.
[http://dx.doi.org/10.1016/j.ejmech.2018.10.036] [PMID: 30347328] 
[41] 
Mulat M, Pandita A, Khan F. Medicinal plant compounds for combating the multi-drug resistant pathogenic bacteria: A review. Curr Pharm Biotechnol  2019; 20(3): 183-96.
[http://dx.doi.org/10.2174/1872210513666190308133429] [PMID: 30854956] 
[42] 
Khan F, Oloketuyi SF, Kim YM. Diversity of bacteria and bacterial products as antibiofilm and antiquorum sensing drugs against pathogenic bacteria. Curr Drug Targets  2019; 20(11): 1156-79.
[http://dx.doi.org/10.2174/1389450120666190423161249] [PMID: 31020938] 
[43] 
Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, Cavanagh J. Anti-biofilm compounds derived from marine sponges. Mar Drugs  2011; 9(10): 2010-35.
[http://dx.doi.org/10.3390/md9102010] [PMID: 22073007] 
[44] 
Sahoo A, Swain SS, Behera A, Sahoo G, Mahapatra PK, Panda SK. Antimicrobial peptides derived from insects offer a novel therapeutic option to combat biofilm: A review. Front Microbiol  2021; 12: 661195.
[http://dx.doi.org/10.3389/fmicb.2021.661195] [PMID: 34248873] 
[45] 
Khan F, Pham DTN, Oloketuyi SF, Manivasagan P, Oh J, Kim YM. Chitosan and their derivatives: Antibiofilm drugs against pathogenic bacteria. Colloids Surf B Biointerfaces  2020; 185: 110627.
[http://dx.doi.org/10.1016/j.colsurfb.2019.110627] [PMID: 31732391] 
[46] 
Khan F, Yu H, Kim YM. Bactericidal activity of usnic acid-chitosan nanoparticles against persister cells of biofilm-forming pathogenic bacteria. Mar Drugs  2020; 18(5): E270.
[http://dx.doi.org/10.3390/md18050270] [PMID: 32443816] 
[47] 
Jahanizadeh S, Yazdian F, Marjani A, Omidi M, Rashedi H. Curcumin-loaded chitosan/carboxymethyl starch/montmorillonite bio-nanocomposite for reduction of dental bacterial biofilm formation. Int J Biol Macromol  2017; 105(Pt 1): 757-63.
[http://dx.doi.org/10.1016/j.ijbiomac.2017.07.101] [PMID: 28746888] 
[48] 
Iadnut A, Mamoon K, Thammasit P, et al. In vitro antifungal and antivirulence activities of biologically synthesized ethanolic extract of propolis-loaded PLGA nanoparticles against Candida albicans. Evid Based Complement Alternat Med  2019; 2019: 3715481.
[http://dx.doi.org/10.1155/2019/3715481] [PMID: 31871479] 
[49] 
Letsididi KS, Lou Z, Letsididi R, Mohammed K, Maguy BL. Antimicrobial and antibiofilm effects of trans-cinnamic acid nanoemulsion and its potential application on lettuce. Lebensm Wiss Technol  2018; 94: 25-32.
[http://dx.doi.org/10.1016/j.lwt.2018.04.018] 
[50] 
Zhang G, Liu J, Li R, et al. Conjugation of inulin improves anti-biofilm activity of chitosan. Mar Drugs  2018; 16(5): E151.
[http://dx.doi.org/10.3390/md16050151] [PMID: 29734657] 
[51] 
Singh A, Gautam PK, Verma A, et al. Green synthesis of metallic nanoparticles as effective alternatives to treat antibiotics resistant bacterial infections: A review. Biotechnol Rep (Amst)  2020; 25: e00427-7.
[http://dx.doi.org/10.1016/j.btre.2020.e00427] [PMID: 32055457] 
[52] 
Khan F, Kang MG, Jo DM, et al. Phloroglucinol-gold and -zinc oxide nanoparticles: Antibiofilm and antivirulence activities towards Pseudomonas aeruginosa PAO1. Mar Drugs  2021; 19(11): 601.
[http://dx.doi.org/10.3390/md19110601] [PMID: 34822472] 
[53] 
Khan F, Manivasagan P, Lee JW, Pham DTN, Oh J, Kim YM. Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in Pseudomonas aeruginosa PAO1. Mar Drugs  2019; 17(4): E208.
[http://dx.doi.org/10.3390/md17040208] [PMID: 30987163] 
[54] 
Grassi L, Maisetta G, Esin S, Batoni G. Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms. Front Microbiol  2017; 8: 2409.
[http://dx.doi.org/10.3389/fmicb.2017.02409] [PMID: 29375486] 
[55] 
Coenye T, Nelis HJ. In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods  2010; 83(2): 89-105.
[http://dx.doi.org/10.1016/j.mimet.2010.08.018] [PMID: 20816706] 
Rights & Permissions Print Cite
Article Metrics
18
1
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1389450123666220429115255	Print ISSN 1389-4501
Publisher Name Bentham Science Publisher	Online ISSN 1873-5592
Current Drug Targets

Strategies for Controlling Biofilm-forming Microbial Pathogens on Biotic and Abiotic Surfaces

Related Journals

Related Books
